Weekly Sepsis Research Analysis
This week’s sepsis literature emphasizes actionable interventions across implementation, mechanistic discovery, and diagnostics. A large pragmatic cluster RCT in Nature Medicine demonstrated that a digitally enabled antibiotic stewardship program can sharply reduce unnecessary antibiotics for respiratory infections without increasing sepsis-related hospitalizations. Mechanistic studies uncovered druggable innate‑immune and epigenetic axes (PP4–CCL5/CCR5 regulating NETosis; NME2–EPC2 control of m
Summary
This week’s sepsis literature emphasizes actionable interventions across implementation, mechanistic discovery, and diagnostics. A large pragmatic cluster RCT in Nature Medicine demonstrated that a digitally enabled antibiotic stewardship program can sharply reduce unnecessary antibiotics for respiratory infections without increasing sepsis-related hospitalizations. Mechanistic studies uncovered druggable innate‑immune and epigenetic axes (PP4–CCL5/CCR5 regulating NETosis; NME2–EPC2 control of microglial NLRP3) linked to organ injury and cognitive dysfunction. Rapid diagnostics and stewardship/RAST approaches promise earlier targeted therapy and measurable mortality benefits in Gram‑negative bacteremia.
Selected Articles
1. Effects of a comprehensive antibiotic stewardship program on antibiotic prescribing for acute respiratory infections in rural facilities: a cluster randomized trial.
A pragmatic cluster RCT across 34 rural township hospitals (97,239 consultations) found a multi-component, digitally enabled stewardship program cut antibiotic prescribing for acute respiratory infections from 71% to 26% (adjusted risk difference −39 percentage points; P<0.001) without increasing 30‑day hospitalizations for respiratory illness or sepsis, supporting scalable stewardship in low‑resource settings.
Impact: Provides high‑quality, real‑world evidence that digital stewardship can substantially reduce unnecessary antibiotic use at scale without compromising short‑term patient safety — directly relevant to antimicrobial resistance and sepsis prevention strategies.
Clinical Implications: Health systems should consider implementing multi-component digital stewardship (EMR prompts, clinician training, peer review, patient education) to reduce inappropriate antibiotics; integrate microbiologic surveillance and monitor resistance patterns longitudinally.
Key Findings
- Antibiotic prescribing for ARIs fell from 71% to 26% with the intervention (adjusted risk difference −39 pp; 95% CI −47 to −29; P<0.001).
- No increase in 30‑day hospitalization for respiratory illness or sepsis was observed.
- Intervention combined EMR prompts, clinician training, peer prescription review, and patient education and was feasible across 34 rural hospitals over 12 months.
2. NME2-driven epigenetic control of inflammasome-activated microglial lineage dynamics promotes sepsis-associated encephalopathy.
Single‑cell RNA‑seq after CLP identified an inflammasome‑activated microglial subset driving neuroinflammation and cognitive deficits in sepsis. NME2 binds the Nlrp3 promoter, recruits EPC2 (NuA4 HAT component), induces H2AK5 acetylation and chromatin remodeling to upregulate Nlrp3. Microglia‑specific Nme2 knockout or stauprimide treatment reduced CSF IL‑1β, neuronal death, and rescued memory in septic mice.
Impact: Identifies a previously unrecognized epigenetic NME2–EPC2–NLRP3 axis in microglia causally linked to sepsis‑associated cognitive impairment and provides genetic and pharmacologic rescue data, highlighting a tractable neuroprotective target.
Clinical Implications: Preclinical but translationally relevant: supports development of selective NME2 modulators or repurposing of agents (e.g., stauprimide analogs) to prevent or treat sepsis‑associated encephalopathy; human validation of axis in CSF/brain tissue is needed.
Key Findings
- scRNA‑seq resolved an inflammasome‑activated microglial subset with upregulated Nlrp3, Il1b, Tnf.
- NME2 directly binds the Nlrp3 promoter and recruits EPC2 to induce H2AK5 acetylation, increasing Nlrp3 transcription.
- Microglia‑specific Nme2 knockout or stauprimide reduced CSF IL‑1β, neuronal death, and rescued memory in septic mice.
3. PP4 modulates macrophage-neutrophil crosstalk to restrict CCL5 -driven NETosis in sepsis.
In myeloid‑specific PP4 knockout mice, loss of PP4 increased susceptibility to CLP or endotoxin challenge through dysregulated macrophage‑derived CCL5 and CCR5‑mediated PAD4‑dependent NETosis, ROS and elastase activity. PP4 dephosphorylates TBK1 to inactivate IRF3 and suppress CCL5; CCR5 inhibition or wild‑type PP4 rescue attenuated neutrophil hyperactivation.
Impact: Identifies PP4 as a tractable regulator of CCL5/CCR5‑driven NETosis and innate immune crosstalk, providing a concrete immunologic axis amenable to pharmacologic or biologic modulation in sepsis.
Clinical Implications: Nominate CCR5 inhibition or strategies to enhance PP4 activity as potential interventions to temper neutrophil hyperactivation and organ injury in sepsis; translational testing and human safety data are required.
Key Findings
- Myeloid PP4 deficiency increased mortality and tissue injury after CLP/LPS.
- PP4 loss augmented macrophage CCL5, driving CCR5‑mediated PAD4‑dependent NETosis, ROS, and elastase activity; CCR5 blockade mitigated effects.
- PP4 dephosphorylates TBK1 to inactivate IRF3 and suppress macrophage CCL5; WT PP4 reconstitution reduced LPS‑induced CCR5 and NETs in neutrophils.